Endoplasmic Reticulum (ER) Stress Inducible Factor Cysteine-Rich with EGF-Like Domains 2 (Creld2) Is an Important Mediator of BMP9-Regulated Osteogenic Differentiation of Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are multipotent progenitors that can undergo osteogenic differentiation under proper stimuli. We demonstrated that BMP9 is one of the most osteogenic BMPs. However, the molecular mechanism underlying BMP9-initiated osteogenic signaling in MSCs remains unclear. Through gene expression profiling analysis we identified several candidate mediators of BMP9 osteogenic signaling. Here, we focus on one such signaling mediator and investigate the functional role of cysteine-rich with EGF-like domains 2 (Creld2) in BMP9-initiated osteogenic signaling. Creld2 was originally identified as an ER stress-inducible factor localized in the ER-Golgi apparatus. Our genomewide expression profiling analysis indicates that Creld2 is among the top up-regulated genes in BMP9-stimulated MSCs. We confirm that Creld2 is up-regulated by BMP9 in MSCs. ChIP analysis indicates that Smad1/5/8 directly binds to the Creld2 promoter in a BMP9-dependent fashion. Exogenous expression of Creld2 in MSCs potentiates BMP9-induced early and late osteogenic markers, and matrix mineralization. Conversely, silencing Creld2 expression inhibits BMP9-induced osteogenic differentiation. In vivo stem cell implantation assay reveals that exogenous Creld2 promotes BMP9-induced ectopic bone formation and matrix mineralization, whereas silencing Creld2 expression diminishes BMP9-induced bone formation and matrix mineralization. We further show that Creld2 is localized in ER and the ER stress inducers potentiate BMP9-induced osteogenic differentiation. Our results strongly suggest that Creld2 may be directly regulated by BMP9 and ER stress response may play an important role in regulating osteogenic differentiation.

[1]  B. He,et al.  P38 and ERK1/2 MAPKs Act in Opposition to Regulate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells , 2012, PloS one.

[2]  Jie Feng,et al.  Association of a BMP9 Haplotype with Ossification of the Posterior Longitudinal Ligament (OPLL) in a Chinese Population , 2012, PloS one.

[3]  T. He,et al.  Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  K. Boström,et al.  Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium. , 2012, Blood.

[5]  Jin Wang,et al.  Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. , 2012, BMB reports.

[6]  H. Nishitoh.  CHOP is a multifunctional transcription factor in the ER stress response. , 2012, Journal of biochemistry.

[7]  T. He,et al.  Conditionally Immortalized Mouse Embryonic Fibroblasts Retain Proliferative Activity without Compromising Multipotent Differentiation Potential , 2012, PloS one.

[8]  I. Adcock,et al.  BMP-9 Induced Endothelial Cell Tubule Formation and Inhibition of Migration Involves Smad1 Driven Endothelin-1 Production , 2012, PloS one.

[9]  J. McClintick,et al.  The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress , 2011, Molecular biology of the cell.

[10]  E. Chosa,et al.  Roles of the endoplasmic reticulum stress transducer OASIS in fracture healing. , 2011, Bone.

[11]  J. Qin,et al.  Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma , 2011, Oncogene.

[12]  K. Oh-hashi,et al.  Biosynthesis and secretion of mouse cysteine‐rich with EGF‐like domains 2 , 2011, FEBS letters.

[13]  N. Solban,et al.  Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth* , 2011, The Journal of Biological Chemistry.

[14]  D. Patra,et al.  Site-1 Protease Is Essential to Growth Plate Maintenance and Is a Critical Regulator of Chondrocyte Hypertrophic Differentiation in Postnatal Mice* , 2011, The Journal of Biological Chemistry.

[15]  N. Faucheux,et al.  BMP‐9‐induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  T. He,et al.  BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. , 2011, Current gene therapy.

[17]  T. Yoneda,et al.  Distinct mechanisms are responsible for osteopenia and growth retardation in OASIS-deficient mice. , 2011, Bone.

[18]  A. Saito,et al.  Endoplasmic Reticulum Stress Response Mediated by the PERK-eIF2α-ATF4 Pathway Is Involved in Osteoblast Differentiation Induced by BMP2* , 2010, The Journal of Biological Chemistry.

[19]  T. He,et al.  Lysophosphatidic Acid Acyltransferase β (LPAATβ) Promotes the Tumor Growth of Human Osteosarcoma , 2010, PloS one.

[20]  T. He,et al.  Retinoic Acids Potentiate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells , 2010, PloS one.

[21]  T. He,et al.  TGFβ/BMP Type I Receptors ALK1 and ALK2 Are Essential for BMP9-induced Osteogenic Signaling in Mesenchymal Stem Cells* , 2010, The Journal of Biological Chemistry.

[22]  T. He,et al.  Insulin-like Growth Factor 2 (IGF-2) Potentiates BMP-9-Induced Osteogenic Differentiation and Bone Formation , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  K. Miyazono,et al.  BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo , 2010, Journal of Cell Science.

[24]  N. Solban,et al.  ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth , 2010, Molecular Cancer Therapeutics.

[25]  M. Goumans,et al.  Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis , 2010, The Journal of experimental medicine.

[26]  T. He,et al.  Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. , 2009, Differentiation; research in biological diversity.

[27]  T. He,et al.  Retinoic acid signalling induces the differentiation of mouse fetal liver‐derived hepatic progenitor cells , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[28]  Hiroshi Sekiya,et al.  Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation , 2009, Nature Cell Biology.

[29]  H. Koga,et al.  CRELD2 is a novel endoplasmic reticulum stress-inducible gene. , 2009, Biochemical and biophysical research communications.

[30]  T. He,et al.  BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling , 2009, Journal of cellular and molecular medicine.

[31]  T. He,et al.  A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. , 2009, Stem cells and development.

[32]  T. He,et al.  Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells* , 2009, Journal of Biological Chemistry.

[33]  A. Montag,et al.  Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects , 2008, Laboratory Investigation.

[34]  L. David,et al.  Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.

[35]  S. Davies,et al.  Site-1 protease is essential for endochondral bone formation in mice. , 2007, The Journal of cell biology.

[36]  Wei Jiang,et al.  Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. , 2007, Gene.

[37]  A. Montag,et al.  Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[38]  K. Kinzler,et al.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system , 2007, Nature Protocols.

[39]  M. V. Dinther,et al.  BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.

[40]  R. Pereira,et al.  CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia. , 2007, Bone.

[41]  C. Maslen,et al.  CRELD2: gene mapping, alternate splicing, and comparative genomic identification of the promoter region. , 2006, Gene.

[42]  S. Akira,et al.  CCAAT/Enhancer-Binding Protein Homologous Protein (CHOP) Regulates Osteoblast Differentiation , 2006, Molecular and Cellular Biology.

[43]  E. Beutler,et al.  Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6 , 2006, Proceedings of the National Academy of Sciences.

[44]  A. Montag,et al.  CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Molecular and Cellular Biology.

[45]  F. Sala,et al.  The cysteine‐rich with EGF‐Like domains 2 (CRELD2) protein interacts with the large cytoplasmic domain of human neuronal nicotinic acetylcholine receptor α4 and β2 subunits , 2005, Journal of neurochemistry.

[46]  J. Wrana,et al.  The disparate role of BMP in stem cell biology , 2005, Oncogene.

[47]  Jiwang Zhang,et al.  BMP signaling and stem cell regulation. , 2005, Developmental biology.

[48]  A. Montag,et al.  Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[49]  J. Szatkowski,et al.  Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery , 2004, Gene Therapy.

[50]  Wei Jiang,et al.  Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[51]  Hongwei Cheng,et al.  Transcriptional characterization of bone morphogenetic proteins (BMPs)‐mediated osteogenic signaling , 2003, Journal of cellular biochemistry.

[52]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[53]  Mallika Singh,et al.  An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis , 2003, Nature Biotechnology.

[54]  J. Blusztajn,et al.  Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. , 2000, Science.

[55]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[56]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[57]  B. Hogan,et al.  Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.

[58]  V. Rosen,et al.  Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. , 1995, Endocrinology.

[59]  A. Montag,et al.  Regulation of osteogenic differentiation during skeletal development. , 2008, Frontiers in bioscience : a journal and virtual library.

[60]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[61]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.

[62]  B. Olsen,et al.  Bone development. , 2000, Annual review of cell and developmental biology.

[63]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.